An interventional study of BFR in Hip Injuries, sponsored by University of Colorado, Denver. Recruiting at 1 site in United States. Open to participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2024-12-11.
Sponsored by University of Colorado, Denver · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 26 studies in Hip Injuries with a site in United States — 7 open to participants now, 10 under way, none of them phase 3. Hip Injuries · United States.
Among the 26 studies in Hip Injuries with a site in United States, this one is the 3rd largest by planned enrollment of the 15 interventional ones that give a count, is one of 4 that started in 2022, is one of 12 with no phase, and was the 19th registered.
66 studies on the registry are indexed under Hip Injuries; 12 are open to participants now.
Browse Hip Injuries studies →7 of the 26 studies in Hip Injuries with a site in United States are open now. Recruiting first, the newest first:
Stryker Endoscopy · Sites in United States
Ages 18+
University Hospitals Cleveland Medical Center · Sites in United States
Ages 14–30 · Healthy volunteers
Zimmer Biomet · Sites in United States
Ages 18+
University of California, Los Angeles · Sites in United States
Zimmer Biomet · Sites in United States
Ages 18+
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 8 Hip Injuries studies recruiting now, 4 set no upper age limit and 2 stop at 75 or younger; 2 take children under 18; 1 takes healthy volunteers.
This study: 18 Years to 60 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
26 studies; the count open now beside each. This study's row is marked.
First in 2007; this study’s year is marked. 4 started in 2022.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 120 is above the median of 61 across 40 interventional studies indexed under Hip Injuries.
Median enrollment 68 across the 15 interventional studies, 50 across the 11 observational. Of the 13 that completed or were terminated, 8 (62%) have results posted.
This tab as a report to print or save as PDF → With an account.
8 of 26 have an industry lead sponsor. The 10 most frequent:
University of Colorado, Denver is the lead sponsor of 1,547 studies on the registry; 318 are open to participants now.
Of its 148 completed or terminated interventional studies of FDA-regulated products, 93 (63%) have results posted.
University of Colorado, Denver has 2 studies filed under Hip Injuries — fewer than ten, so there is no comparison to draw.
4 of the studies in Hip Injuries with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05112302Mayo ClinicA Study to Evaluate Virtual Reality As Adjunct to Anesthesia During Orthopedic Surgery | 2026-12 |
| NCT05488054University Hospitals Cleveland Medical CenterMuscle O2 Saturation and Hemoglobin Levels During Rehabilitation From Arthroscopic Surgery | 2026-12 |
| NCT04937868University of California, Los AngelesDeveloping a Decision Instrument to Guide Abdominal-pelvic CT Imaging of Blunt Trauma Patients | 2027-01-15 |
| NCT05199870Zimmer BiometMDR - PMCF Study for RingLoc Bipolar Acetabular Cup and Endo II Femoral Heads | 2027-03 |
Add all 4 to your calendar (.ics) → With an account.
Among the 26 studies in Hip Injuries with a site in United States, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
The investigators plan to investigate the efficacy of blood flow restriction (BFR) therapy in post operative rehabilitation following hip arthroscopy. BFR has shown to be great at helping the recovery process. SAGA is a well-known smart training technology company, and the investigators aim to partner with SAGA to use the BFR cuffs as the intervention method. The BFR cuff will be added to the current SOC for hip scope PT for the intervention group.
Study Design and Research Methods i. Timeline: Treatment Protocol duration 12 weeks per participant beginning post operative day 1 following hip arthroscopy. PRO's will be collected out to 2 years post-surgery and standard rehabilitation will follow the 12-week intervention period for both the control and experimental group. Study will be a 2-year timeline in total.
ii. Procedures: Patients will be randomized to control group, who will undergo Steadman Hawkins Clinic Denver's standard hip arthroscopy rehab protocol (see appendix) or to the intervention group, who will undergo standard rehab protocol with addition of BFR. Subjects will be randomized 1:1 for intervention vs. control and controlled for gender assigned at birth.
iii. Frequency of BFR Training: 6 days per week phase 1, 3 days per week phases 2 and 3 iv. Frequency of clinic visits PT: 1 day per week v. Intervention Group: The following exercises outlined are the specific exercises that will be performed in addition to SOC. Only these exercises will involve the use of the BFR cuff.
Phase 1 (post operative weeks 1-3)
i. Week 1: quadriceps set, gluteal set, hamstring set ii. Week 2: short arc quad, hook lying adduction/internal rotation isometric, hook lying abduction/external rotation isometric iii. Week 3: long arc quad, bridge, standing hamstring curl
Phase 2 (weeks 4-6)
i. Week 4: mini squat, prone hip extension over plinth, quadruped rock ii. Week 5: mid-range squat, modified single leg bridge foot on ball, heel slide strap assist iii. Week 6: step up, standing hip abduction, single leg bridge
Phase 3 (weeks 6-12)
a. Dosage: 80% LOP at 20-30% 1 RM.1 RM re-evaluated every 2 weeks to adjust resistance prescription. 30x15x15x15 repetitions with 30 sec rests between sets. At least 1 min rest between exercises with occlusion OFF b. Frequency: All 3 resistive exercises performed at least 3 days per week. The first of these sessions will be performed in clinic supervised by PT to assess LOP and form prior to performance at home c. Exercises: i. Weeks 6-12: Single leg squat to 45 deg knee flexion (holding weight as tolerated), single leg Romanian dead lift (holding weight a weight as tolerated), Bulgarian split squat (holding a weight as tolerated)
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
bilateral hip surgeries to be performed within 12 weeks of each other, concomitant Peri-acetabular osteotomy, soft tissue repairs (hamstring, glute repairs), clinically diagnosed hip dysplasia, and the following BFR :
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
BFR cuffs will be used for specific exercises and added to the current SOC for post hip scope PT.
Device: BFR
Current SOC for post hip scope PT will be assigned.
BFR cuffs will be used at home during specified exercises in addition to SOC for post hip scope PT.
Hip extensor strength
1. Strength of hip extensors via handheld dynamometry (HHD) and reported as a measure of limb symmetry index (LSI) comparing operative limb to non-operative limb. By 3 months post operatively, patients should be approaching 70% LSI in order to safely initiate impact activities such as jogging. Prior to discharge from therapy, patients should achieve at least 90% LSI per standard protocol.
Time frame: 2 Years
additional hip musculature strength
1. Strength of hip flexors, abductors and adductors via handheld dynamometry (HHD) and reported as a measure of limb symmetry index (LSI) comparing operative limb to non-operative limb. By 3 months post operatively, patients should be approaching 70% LSI in order to safely initiate impact activities such as jogging. Prior to discharge from therapy, patients should achieve at least 90% LSI per standard protocol.
Time frame: 2 Years
single leg squat test
2. Performance on a Repeated Single Leg Squat test to 45 deg knee flexion over the course of 90 seconds reported as a measure of LSI. Prior to initiation of impact activities such as jogging (usually around 3 months), patient should be approaching 70% LSI per standard protocol and 90% by time of discharge.
Time frame: 2 Years
i-HOT
Range 0 (poor health) - 100 (good health); MCD = Δ13
Time frame: 2 Years
LEFS
Range 0 (extreme difficulty) - 100 (extreme difficulty); MDIC = Δ 123
Time frame: 2 Years
PROMIS pain
PROMIS Pain: Range 0 (low pain) - 100 (high pain); MDC = Δ 85.
Time frame: 2 Years
Brief Resiliency Score
Range 1 (low resilience) - 5 (high resilience)
Time frame: 2 Years
PROMIS physical function
PROMIS Physical Function: Range 0 (low function) - 100 (high function); MDC = Δ 85
Time frame: 2 Years
range of motion (ROM)
MDC = Δ low (1-2.99) to normal (3-4.3) to high (4.31-5)
Time frame: 2 Years
Tegner Activity Scale
Range 0 (disability because of knee problems) - 10 (national or international level soccer)
Time frame: 2 Years
PDFs hosted by the registry, ClinicalTrials.gov.
Started Apr 2022 (actual). Primary completion is estimated for Dec 2025, 44 months after the start.
Of 26 non-industry interventional studies with no phase under Hip Injuries, half reached primary completion within 26 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 65. This study's planned 44 months is above that.
Counting every sponsor, half of 28 studies reached it within 26 months; a quarter within 8 and three quarters within 65.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Colorado, Denver →